| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Follicle | 17 | 2025 | 124 | 3.890 |
Why?
|
| Ovary | 20 | 2025 | 369 | 3.530 |
Why?
|
| Oocytes | 16 | 2025 | 290 | 3.080 |
Why?
|
| Sumoylation | 5 | 2025 | 41 | 2.990 |
Why?
|
| Granulosa Cells | 16 | 2019 | 140 | 2.770 |
Why?
|
| Fertility | 10 | 2021 | 258 | 2.140 |
Why?
|
| Reproduction | 5 | 2025 | 226 | 1.990 |
Why?
|
| Oogenesis | 7 | 2025 | 55 | 1.950 |
Why?
|
| Germ Cells | 6 | 2023 | 204 | 1.510 |
Why?
|
| Granulosa Cell Tumor | 10 | 2019 | 38 | 1.450 |
Why?
|
| Inhibins | 6 | 2013 | 87 | 1.370 |
Why?
|
| Smad Proteins | 5 | 2016 | 43 | 1.280 |
Why?
|
| Transforming Growth Factor beta | 8 | 2017 | 473 | 1.270 |
Why?
|
| Signal Transduction | 17 | 2021 | 4710 | 1.100 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2025 | 39 | 1.020 |
Why?
|
| Animals | 53 | 2025 | 34804 | 0.970 |
Why?
|
| Mice | 38 | 2025 | 18478 | 0.960 |
Why?
|
| Primary Ovarian Insufficiency | 4 | 2021 | 45 | 0.950 |
Why?
|
| Mice, Knockout | 24 | 2025 | 3865 | 0.940 |
Why?
|
| Giant Cells | 1 | 2025 | 35 | 0.930 |
Why?
|
| Homeodomain Proteins | 5 | 2023 | 574 | 0.920 |
Why?
|
| Myostatin | 1 | 2025 | 23 | 0.900 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2011 | 294 | 0.900 |
Why?
|
| Infertility, Female | 5 | 2019 | 149 | 0.830 |
Why?
|
| Ovarian Neoplasms | 6 | 2016 | 462 | 0.790 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2023 | 117 | 0.780 |
Why?
|
| Integrases | 2 | 2023 | 159 | 0.780 |
Why?
|
| Estrous Cycle | 2 | 2021 | 36 | 0.750 |
Why?
|
| Smad5 Protein | 3 | 2014 | 21 | 0.700 |
Why?
|
| Smad1 Protein | 3 | 2014 | 22 | 0.700 |
Why?
|
| Growth Differentiation Factor 9 | 7 | 2013 | 46 | 0.690 |
Why?
|
| Smad4 Protein | 3 | 2012 | 57 | 0.690 |
Why?
|
| Female | 52 | 2025 | 70643 | 0.650 |
Why?
|
| Cytokines | 4 | 2021 | 1365 | 0.620 |
Why?
|
| Transcription Factors | 8 | 2023 | 2497 | 0.610 |
Why?
|
| Meiosis | 4 | 2015 | 116 | 0.610 |
Why?
|
| Cell Communication | 1 | 2019 | 186 | 0.590 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 1036 | 0.570 |
Why?
|
| Aging | 1 | 2025 | 1249 | 0.560 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2012 | 126 | 0.520 |
Why?
|
| Menopause | 1 | 2017 | 90 | 0.520 |
Why?
|
| Reproductive Health | 1 | 2017 | 49 | 0.510 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 2442 | 0.510 |
Why?
|
| Ovulation | 8 | 2012 | 107 | 0.500 |
Why?
|
| Oviducts | 1 | 2016 | 100 | 0.490 |
Why?
|
| Longevity | 1 | 2017 | 159 | 0.480 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 21 | 0.480 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2019 | 1017 | 0.480 |
Why?
|
| Fallopian Tubes | 1 | 2016 | 76 | 0.470 |
Why?
|
| Uterus | 3 | 2016 | 548 | 0.470 |
Why?
|
| Spermatogenesis | 2 | 2015 | 176 | 0.450 |
Why?
|
| Activins | 4 | 2013 | 73 | 0.440 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 633 | 0.390 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 44 | 0.380 |
Why?
|
| Gonadotropins | 2 | 2015 | 32 | 0.360 |
Why?
|
| Egg Proteins | 2 | 2012 | 29 | 0.360 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2023 | 373 | 0.330 |
Why?
|
| Luteinization | 2 | 2010 | 12 | 0.330 |
Why?
|
| Embryo Implantation | 3 | 2016 | 231 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2015 | 2057 | 0.290 |
Why?
|
| Inhibin-beta Subunits | 1 | 2007 | 20 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 4757 | 0.270 |
Why?
|
| Humans | 32 | 2025 | 132013 | 0.250 |
Why?
|
| Adipose Tissue, White | 2 | 2024 | 94 | 0.250 |
Why?
|
| Testis | 2 | 2007 | 422 | 0.250 |
Why?
|
| Gonads | 1 | 2004 | 34 | 0.230 |
Why?
|
| Transforming Growth Factors | 1 | 2004 | 20 | 0.230 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 684 | 0.220 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 722 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 574 | 0.220 |
Why?
|
| Carcinogenesis | 3 | 2019 | 358 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2015 | 1964 | 0.210 |
Why?
|
| Proteins | 3 | 2023 | 1036 | 0.210 |
Why?
|
| Zygote | 1 | 2023 | 30 | 0.200 |
Why?
|
| Gene Deletion | 3 | 2021 | 793 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 15 | 5 | 2007 | 42 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 2447 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1285 | 0.190 |
Why?
|
| Male | 15 | 2025 | 64914 | 0.190 |
Why?
|
| Lysine | 1 | 2023 | 185 | 0.190 |
Why?
|
| Mammals | 1 | 2023 | 271 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 1045 | 0.180 |
Why?
|
| Tissue Engineering | 1 | 2003 | 167 | 0.180 |
Why?
|
| Bioreactors | 1 | 2002 | 42 | 0.180 |
Why?
|
| Energy Metabolism | 2 | 2024 | 785 | 0.180 |
Why?
|
| Periodicity | 1 | 2021 | 50 | 0.180 |
Why?
|
| Models, Genetic | 1 | 2004 | 771 | 0.180 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 1423 | 0.180 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 28 | 0.170 |
Why?
|
| Adipocytes, White | 1 | 2021 | 27 | 0.170 |
Why?
|
| Lipodystrophy | 1 | 2021 | 33 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 62 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 386 | 0.170 |
Why?
|
| Growth Substances | 1 | 2000 | 109 | 0.170 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2019 | 3 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 623 | 0.160 |
Why?
|
| Models, Biological | 4 | 2015 | 1443 | 0.160 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2010 | 193 | 0.150 |
Why?
|
| Smad2 Protein | 2 | 2009 | 54 | 0.150 |
Why?
|
| Smad3 Protein | 2 | 2009 | 58 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4684 | 0.150 |
Why?
|
| Neoplasms | 1 | 2013 | 2956 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2015 | 106 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1882 | 0.140 |
Why?
|
| Genitalia | 1 | 2017 | 38 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2007 | 1350 | 0.140 |
Why?
|
| Genetic Fitness | 1 | 2017 | 36 | 0.130 |
Why?
|
| Age Factors | 2 | 2017 | 2911 | 0.130 |
Why?
|
| Health Status Indicators | 1 | 2017 | 128 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 679 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 131 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 420 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1710 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 468 | 0.120 |
Why?
|
| Placentation | 1 | 2015 | 60 | 0.120 |
Why?
|
| Health Status | 1 | 2017 | 407 | 0.110 |
Why?
|
| Forkhead Box Protein O3 | 2 | 2015 | 31 | 0.110 |
Why?
|
| Cumulus Cells | 3 | 2010 | 44 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 133 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2006 | 380 | 0.100 |
Why?
|
| Pregnancy | 5 | 2016 | 7554 | 0.100 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 469 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 35 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 254 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 87 | 0.100 |
Why?
|
| Gene Expression | 3 | 2007 | 1560 | 0.100 |
Why?
|
| Ligands | 2 | 2004 | 494 | 0.100 |
Why?
|
| Base Sequence | 3 | 2006 | 2900 | 0.090 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 236 | 0.090 |
Why?
|
| Enterococcus | 1 | 2012 | 31 | 0.090 |
Why?
|
| Organ Size | 1 | 2013 | 446 | 0.090 |
Why?
|
| Animals, Newborn | 3 | 2011 | 1033 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 844 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 420 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 13 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 146 | 0.080 |
Why?
|
| TATA-Binding Protein Associated Factors | 2 | 2007 | 14 | 0.080 |
Why?
|
| Transcription Factor TFIID | 2 | 2007 | 17 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 996 | 0.080 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2010 | 10 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 688 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 266 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2012 | 1080 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2010 | 31 | 0.080 |
Why?
|
| Colitis | 1 | 2012 | 165 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1829 | 0.080 |
Why?
|
| Hedgehog Proteins | 2 | 2010 | 263 | 0.080 |
Why?
|
| Aromatase | 1 | 2009 | 24 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 450 | 0.080 |
Why?
|
| Receptors, FSH | 1 | 2009 | 20 | 0.080 |
Why?
|
| Sexual Maturation | 1 | 2009 | 46 | 0.080 |
Why?
|
| Apoptosis | 2 | 2014 | 1899 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 308 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2019 | 879 | 0.080 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2009 | 43 | 0.080 |
Why?
|
| Genomics | 1 | 2017 | 1650 | 0.070 |
Why?
|
| Multigene Family | 1 | 2010 | 305 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2509 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1282 | 0.070 |
Why?
|
| Smad8 Protein | 1 | 2007 | 5 | 0.070 |
Why?
|
| Sertoli Cell Tumor | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cell Line | 2 | 2004 | 2725 | 0.070 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2007 | 10 | 0.070 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2007 | 7 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 2007 | 25 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 326 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2010 | 280 | 0.070 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 131 | 0.060 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2006 | 42 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 224 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 440 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1572 | 0.060 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2005 | 9 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 3771 | 0.060 |
Why?
|
| Spermatocytes | 1 | 2004 | 24 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 636 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 173 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2007 | 2679 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2007 | 3043 | 0.060 |
Why?
|
| Cholesterol | 1 | 2007 | 558 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 72 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 252 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2004 | 70 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2003 | 6 | 0.050 |
Why?
|
| Glucuronic Acid | 1 | 2003 | 14 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 2669 | 0.050 |
Why?
|
| Heterozygote | 1 | 2006 | 713 | 0.050 |
Why?
|
| Alginates | 1 | 2003 | 24 | 0.050 |
Why?
|
| Microspheres | 1 | 2003 | 73 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2005 | 215 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 615 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2004 | 161 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 338 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4526 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 764 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 327 | 0.050 |
Why?
|
| Hydrogels | 1 | 2003 | 108 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10931 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2002 | 2 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2002 | 29 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 287 | 0.050 |
Why?
|
| Chromatography | 1 | 2002 | 38 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 70 | 0.050 |
Why?
|
| Exons | 1 | 2004 | 804 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1095 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2007 | 1047 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 83 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2002 | 158 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 180 | 0.040 |
Why?
|
| Biological Assay | 1 | 2002 | 111 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 242 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 703 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 87 | 0.040 |
Why?
|
| Adipokines | 1 | 2021 | 77 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 552 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1671 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2000 | 54 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 2000 | 81 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Infant | 2 | 2016 | 13050 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2016 | 14736 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 550 | 0.040 |
Why?
|
| Mutation | 2 | 2007 | 6226 | 0.030 |
Why?
|
| Child | 3 | 2016 | 25765 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 36 | 0.030 |
Why?
|
| Puberty, Precocious | 1 | 2016 | 29 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2016 | 169 | 0.030 |
Why?
|
| Adolescent | 2 | 2016 | 20544 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1996 | 141 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 248 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2021 | 698 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 888 | 0.030 |
Why?
|
| Keratin-8 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 49 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 54 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 393 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 97 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 423 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 85 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Decidua | 1 | 2015 | 138 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 61 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2015 | 118 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1996 | 260 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 79 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 1989 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6441 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 39 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 351 | 0.020 |
Why?
|
| Adult | 4 | 2015 | 31563 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1360 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 866 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 47 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 302 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 438 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 541 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 394 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 679 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1305 | 0.020 |
Why?
|
| Hormones | 1 | 2010 | 170 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1125 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2007 | 67 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 5008 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3682 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 222 | 0.020 |
Why?
|
| Glycolysis | 1 | 2007 | 165 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 377 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 946 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 422 | 0.020 |
Why?
|
| X Chromosome | 1 | 2007 | 340 | 0.010 |
Why?
|
| Pyrroles | 1 | 2007 | 182 | 0.010 |
Why?
|
| Interferon Inducers | 1 | 2005 | 6 | 0.010 |
Why?
|
| Poly I-C | 1 | 2005 | 24 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 651 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2005 | 66 | 0.010 |
Why?
|
| Hyaluronan Synthases | 1 | 2004 | 12 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 283 | 0.010 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 14 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 66 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2004 | 40 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 325 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 129 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 62 | 0.010 |
Why?
|
| Interferons | 1 | 2005 | 142 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 269 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 127 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 376 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2004 | 173 | 0.010 |
Why?
|
| ROC Curve | 1 | 2004 | 600 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 605 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 584 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 464 | 0.010 |
Why?
|
| Activin Receptors | 1 | 2000 | 14 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 17 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12987 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 1283 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2000 | 92 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 454 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 569 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 811 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 862 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 2311 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17374 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 36 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1996 | 31 | 0.010 |
Why?
|
| Heat Shock Transcription Factors | 1 | 1996 | 20 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 67 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1996 | 412 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 28968 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1996 | 363 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1996 | 731 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 1045 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 827 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 153 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 361 | 0.010 |
Why?
|
| Monocytes | 1 | 1996 | 342 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1133 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 3606 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1996 | 1610 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 1478 | 0.010 |
Why?
|
| Inflammation | 1 | 1996 | 1519 | 0.000 |
Why?
|